Stocks in Play

Ventripoint Diagnostics Ltd

12:04 PM EST - Ventripoint Diagnostics Ltd : Announces that its strategic partner, Lishman Global Inc., has formally submitted Ventripoint’s VMS+™ 4.0 system to China’s National Medical Products Administration, commonly referred to as the Chinese FDA, for regulatory approval. Ventripoint Diagnostics Ltd shares V.VPT are trading off $0.01 at $0.10.

Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=VPT%3ACA&qmodStoryID=8415463641057025